COR2ED The Heart of Medical Education
Our COR2ED channel brings together world-renowned medical experts to discuss and provide clear guidance on the latest scientific and clinical insights in various therapeutic areas, including oncology, cardiology, hemostasis, rare diseases, hemato-oncology, and endocrinology. At COR2ED, we are committed to providing balanced and evidence-based independent medical education to support healthcare ...
read more ↘
read more ↘
Tools for Optimizing Management of Advanced NETs
This video, developed by Prof. Emily Bergsland and Asst Prof. Louis de Mestier, provides you with an overview of tools for optimising treatment and management of advanced NETs, focusing on a variety of tumour-, patient-, and treatment-related factors.
Topics covered in this video include:
- NEN incidence increases over time with gastroenteropancreatic NETs (GEP-NETs) being the most common well-differentiated NETs
- Despite advances in recent years, there remain challenges and unmet needs related to the treatment and management of advanced NETs
- When considering the tools to optimise the treatment and management of advanced NETs, always integrate efficacy, QoL, and both short- and long-term toxicity in addition to tumour-related factors when choosing the treatment strategy
Download the slides and summary flashcard and access the accredited e-learning here.
Clinical takeaways:
- Outcomes depend on tumour location, size, distribution, and hepatic extent of metastases as well as tumour growth rate
- Involvement of the patient, as well as a multidisciplinary team, in decision-making is essential
- Always take quality of life (QoL) and long-term toxicity into account when choosing therapy
Follow NET CONNECT on social media:
X
LinkedIn
The medical experts in this video are expressing their own views and not those of COR2ED, Supporters or their institution. This video is supported by an Independent Medical Education Grant from Ipsen.
This content is intended for healthcare professionals only.
This video is developed by cor2ed.com
Publication date: JULY 2024
Topics covered in this video include:
- NEN incidence increases over time with gastroenteropancreatic NETs (GEP-NETs) being the most common well-differentiated NETs
- Despite advances in recent years, there remain challenges and unmet needs related to the treatment and management of advanced NETs
- When considering the tools to optimise the treatment and management of advanced NETs, always integrate efficacy, QoL, and both short- and long-term toxicity in addition to tumour-related factors when choosing the treatment strategy
Download the slides and summary flashcard and access the accredited e-learning here.
Clinical takeaways:
- Outcomes depend on tumour location, size, distribution, and hepatic extent of metastases as well as tumour growth rate
- Involvement of the patient, as well as a multidisciplinary team, in decision-making is essential
- Always take quality of life (QoL) and long-term toxicity into account when choosing therapy
Follow NET CONNECT on social media:
X
The medical experts in this video are expressing their own views and not those of COR2ED, Supporters or their institution. This video is supported by an Independent Medical Education Grant from Ipsen.
This content is intended for healthcare professionals only.
This video is developed by cor2ed.com
Publication date: JULY 2024
Comments 0
Login to view comments.
Click here to Login
